Commure vs Suki (2026)

AI Health Index verifiedJuly 22, 2026
Verdict

If your failure mode is buying an enterprise scribe without deciding which direction the note should flow, this pair is the fork. Both are model first and both sell sales led enterprise contracts with no published price, so the choice is not price or ambience quality. Commure pushes the note downstream into the revenue cycle: ambient documentation feeds autonomous coding, clinical documentation integrity, and claims automation, a stack for a system that wants one contract from encounter to bill. Suki pushes the note sideways into the clinical workflow: a voice command layer over the EHR that stages orders, navigates charts, and answers questions against the specific patient record, with deep bidirectional integrations across five major systems. Pick by where you want the leverage, billing or bedside.

The case for Commure
  • The note becomes revenue: ambient documentation flows into autonomous coding, CDI, and claims automation, so the leverage lands in the revenue cycle rather than at the point of order entry.
  • Reach is broad across more than 50 EHRs including Epic, Oracle Health, and MEDITECH, ambulatory and acute, with a January 2025 Vizient contract giving member systems negotiated access.
  • Human oversight is a purchasable structure across Go, Assist, and Live, useful for a system standardizing documentation policy across many service lines.
The case for Suki
  • The command layer is the difference: clinicians issue voice commands to order medications, navigate charts, stage orders for review, and query the record, which a passive scribe cannot do.
  • The deepest EHR surface in this pair: bidirectional integrations across Epic, Oracle Health, athenahealth, MEDITECH, and Elation, plus a Platform that lets other software vendors embed the capability.
  • The autonomy ceiling is set sensibly: voice commands stage orders for clinician review rather than submitting them, keeping a human decision between the model and any clinical action.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Commure and Suki are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Commure Suki
Primary category Ambient Scribes Ambient Scribes
Founded 2017 2017
Headquarters Mountain View, California Redwood City, California
Website commure.com suki.ai
Attribute Matrix

Side by Side

Axis
C
Commure
S
Suki
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

Commure

The AI Health Index awards Commure its top capability grade on AI Centrality. Set against Suki, Commure does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, July 2026

Suki

The AI Health Index awards Suki its top capability grade on AI Centrality and EHR and Interoperability Depth. Set against Commure, Suki grades higher on Model Supply Chain Disclosure, AI Liability and Recourse and EHR and Interoperability Depth. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, July 2026

FAQ

Questions buyers ask

Should we choose Commure or Suki?

The AI Health Index grades Suki higher than Commure on every axis that separates them, Model Supply Chain Disclosure, AI Liability and Recourse and EHR and Interoperability Depth. Commure does not grade higher on any scored axis.

Where do Commure and Suki differ most?

The widest separation the AI Health Index records between Commure and Suki is on Model Supply Chain Disclosure, where Commure grades D and Suki grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.

Where do Commure and Suki grade the same?

The AI Health Index grades Commure and Suki the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

What have Commure and Suki not disclosed?

At the last review, at least one of Commure and Suki published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.

Disclosure

Neither vendor publishes pricing, so both are recorded as contact the vendor and left ungraded on commercial transparency; third party listings place Suki near 299 to 399 dollars per provider a month, the most expensive scribe in the lane by estimate, while Commure's enterprise pricing is undisclosed.

Suki's command interpretation accuracy and its escalation behavior when a command is misheard are not published, which matters more than a note error because a misinterpreted medication order carries higher consequence. Commure's grid is vendor published across nine axes with no independent clinical evidence assessed, and its SOC 2 Type 2 reference attaches to its data centers rather than to Commure itself.